BioCentury
ARTICLE | Financial News

Theradiag slips in Euronext trading debut

December 12, 2012 2:54 AM UTC

Diagnostics company Theradiag (Euronext:ALTER) was down EUR 0.14 to EUR 5.66 in its first day of trading Tuesday on NYSE Euronext Paris. Last week, the company raised EUR 8.2 million ($10.6 million) t...